Compare Public Storage (PSA) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Public Storage vs State Street SPDR S&P Biotech ETF — how do they compare? Public Storage trades at $286.09 (market cap $53.35B), while State Street SPDR S&P Biotech ETF trades at $149.89 (market cap $10.11B). The key difference: Public Storage is far larger — about 5.3× State Street SPDR S&P Biotech ETF's market cap, and Public Storage pays a 4.2% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Public Storage for 130 Days and State Street SPDR S&P Biotech ETF for 37 Days on average.
| PSA | XBI | |
|---|---|---|
Market Cap | $53.35B | $10.11B |
Volume | 1,176,034 | 12,903,266 |
Sector | Real Estate | Broad Market / Factor |
52-Week High | $330.47 | $169.55 |
52-Week Low | $258.44 | $104.99 |
Typical Hold Time | 130 Days | 37 Days |
Enterprise Value | $67.62B | — |
Dividend Yield | 4.2% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Public Storage (PSA) trades at $281.99, down 1.35% on the day, with a bearish technical signal and mixed sentiment. The stock exhibits strong profitability with a 41.8% net income margin and consistent earnings beats, but faces headwinds from negative net cash flow trends. Recent developments include the completion of the Public Storage Canada acquisition and a $400 million senior notes offering in the Canadian market, signaling expansion efforts.
PSA presents a cautious outlook with a consensus price target of $328.33 implying upside, yet technical indicators and cash flow concerns weigh. Investment opportunities lie in its high margins and dividend yield, while risks include operational execution amid interest rate sensitivity and competitive pressures in the REIT sector.
XBI trades at $150.23, down 0.44% on the day, with a bearish technical signal driven by moving averages and oscillators. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts. Recent news highlights sector optimism from cancer vaccine breakthroughs and improved capital access, though the ETF carries higher volatility than broader healthcare funds.
The outlook is mixed: strong sector tailwinds from innovation and consolidation support growth potential, but high volatility and expense ratios relative to peers pose risks. Analyst sentiment is neutral with 100% hold ratings, suggesting cautious optimism amid technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Public Storage
Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
